Clinical trial
Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft…
NCT00447642 · Lux Biosciences, Inc., Industry · Terminated
Key facts
| NCT number | NCT00447642 |
|---|---|
| Title | Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating Keratoplasty |
| Official title | A Multi-center, Placebo-Controlled, Randomized, Parallel-Group, Dose-Ranging Study to Assess the Efficacy and Safety of LX201 Implantation for the Prevention of Corneal Allograft Rejection Episodes or Graft Failure in Subjects Who Have Experienced One or More Rejection Episodes Following Penetrating… |
| Lead sponsor | Lux Biosciences, Inc., Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Corneal Transplantation, Corneal Graft Rejection |
| Intervention type | Drug, Other |
| Interventions | LX201, Placebo |
| Enrollment | 122 |
| Start date | Apr 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Jan 1, 2010 |
| First posted | Mar 15, 2007 |
| Last update posted | Oct 11, 2012 |
| Countries | Germany, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: